Reports & Studies

The importance of the pharmaceutical industry for Switzerland

Study on behalf of Interpharma

The pharmaceutical industry is an important pillar of Switzerland’s economy. The gross value added achieved in Switzerland in 2018 amounted to around 36.0 billion francs, accounting for 5.4 per cent of Switzerland’s total economic output. Without the strong real value-added growth of 9.3 per cent per annum on average in the pharmaceutical industry, Swiss GDP growth would have been a third lower between 2008 and 2018. Other sectors also benefited from the success of the pharmaceutical industry: including the value chains involved in companies from other sectors, pharmaceutical activities contributed to around 62.1 billion francs in value added in 2018.

Report in english